Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer.

Manish A ShahYoon-Koo KangPeter C Thuss-PatienceAtsushi OhtsuJaffer A AjaniEric Van CutsemSilke HoerschMarie-Laurence Harle-YgeSanne Lysbet de Haas

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2019)

NCT01641939 ( https://clinicaltrials.gov/ct2/show/NCT01641939 ).

Keyphrases

metastatic breast cancer
papillary thyroid
epidermal growth factor receptor
squamous cell
magnetic resonance imaging
contrast enhanced
image quality
squamous cell carcinoma
dual energy
positron emission tomography
tyrosine kinase
pet ct